E11/Podoplanin Protein Stabilization Through Inhibition of the Proteasome Promotes Osteocyte Differentiation in Murine in Vitro Models

Article English OPEN
Staines, Katherine A. ; Prideaux, Matt ; Allen, Steve ; Buttle, David J. ; Pitsillides, Andrew A. ; Farquharson, Colin (2015)
  • Publisher: John Wiley and Sons Inc.
  • Journal: Journal of Cellular Physiology (issn: 0021-9541, vol: 231, pp: 1,392-1,404)
  • Related identifiers: doi: 10.1002/jcp.25282, pmc: PMC4832367
  • Subject: Original Research Articles | Original Research Article
    mesheuropmc: embryonic structures

The transmembrane glycoprotein E11 is considered critical in early osteoblast–osteocyte transitions (osteocytogenesis), however its function and regulatory mechanisms are still unknown. Using the late osteoblast MLO‐A5 cell line we reveal increased E11 protein/mRNA expression (P < 0.001) concomitant with extensive osteocyte dendrite formation and matrix mineralization (P < 0.001). Transfection with E11 significantly increased mRNA levels (P < 0.001), but immunoblotting failed to detect any correlative increases in E11 protein levels, suggestive of post‐translational degradation. We found that exogenous treatment of MLO‐A5 and osteocytic IDG‐SW3 cells with 10 μM ALLN (calpain and proteasome inhibitor) stabilized E11 protein levels and induced a profound increase in osteocytic dendrite formation (P < 0.001). Treatment with other calpain inhibitors failed to promote similar osteocytogenic changes, suggesting that these effects of ALLN rely upon its proteasome inhibitor actions. Accordingly we found that proteasome‐selective inhibitors (MG132/lactacystin/ Bortezomib/Withaferin‐A) produced similar dose‐dependent increases in E11 protein levels in MLO‐A5 and primary osteoblast cells. This proteasomal targeting was confirmed by immunoprecipitation of ubiquitinylated proteins, which included E11, and by increased levels of ubiquitinylated E11 protein upon addition of the proteasome inhibitors MG132/Bortezomib. Activation of RhoA, the small GTPase, was found to be increased concomitant with the peak in E11 levels and its downstream signaling was also observed to promote MLO‐A5 cell dendrite formation. Our data indicate that a mechanism reliant upon blockade of proteasome‐mediated E11 destabilization contributes to osteocytogenesis and that this may involve downstream targeting of RhoA. This work adds to our mechanistic understanding of the factors regulating bone homeostasis, which may lead to future therapeutic approaches. J. Cell. Physiol. 231: 1392–1404, 2016. © 2015 The Authors. Journal of Cellular Physiology published by Wiley Periodicals, Inc.
  • References (64)
    64 references, page 1 of 7

    Arnsdorf EJ, Tummala P, Kwon RY, Jacobs CR. 2009. Mechanically induced osteogenic differentiation-the role of RhoA, ROCKII, and cytoskeletal dynamics. J Cell Sci 122:546-553.

    Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den Ende J, Willems P, Paes-Alves AF, Hill S, Bueno M, Ramos FJ, Tacconi P, Dikkers FG, Stratakis C, Lindpaintner K, Vickery B, Foernzler D, Van Hul W. 2001. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Gen 10:537-543.

    Barragan-Adjemian C, Nicolella D, Dusevich V, Dallas MR, Eick JD, Bonewald LF. 2006. Mechanism by which MLO-A5 late osteoblasts/early osteocytes mineralize in culture: Similarities with mineralization of lamellar bone. Calcif Tissue Int 79:340-353.

    Bonewald LF. 2002. Osteocytes: A proposed multifunctional bone cell. J Musculoskelet Neuronal Interact 2:239-241.

    Bonewald LF. 2007. Osteocyte messages from a bony tomb. Cell Metab 5:410-411.

    Bonewald LF. 2012. The amazing osteocyte. J Bone Miner Res 26:229-238.

    Butkinaree C, Park K, Hart GW. 2010. O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim Biophys Acta 1800:96-106.

    Butler JE, Moore MB, Presnell SR, Chan HW, Chalupny NJ, Lutz CT. 2009. Proteasome regulation of ULBP1 transcription. J Immunol 182:6600-6609.

    Cao YX, Ramirez MI, Williams MC. 2003. Enhanced binding of Sp1/Sp3 transcription factors mediates the hyperoxia-induced increased expression of the lung type I cell gene T1alpha. J Cell Biochem 89:887-901.

    Dallas SL, Prideaux M, Bonewald LF. 2013. The osteocyte: An endocrine cell. . .and more. Endocr Rev 34:658-690.

  • Metrics
    No metrics available
Share - Bookmark